Scholars Central

Conference abstractPublished 15 Oct 2013

Morphological changes in HIV-1 infected patients on antiretroviral therapy without protease inhibitors in Cameroon: A prospective cohort study

Authors: Nguemaim N. F, Mbuagbaw J, Teto G, Nkoa T, Same-Ekobo A, Asonganyi T

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Data on morphological derangements induced by antiretroviral treatment in Cameroon are scarce. The aim of this study was to determine the effect of HIV infection and of antiretroviral therapy on lipid metabolism in order to help the clinicians to improve the management of HIV-infected patients. The lipid profile of 700 subjects of which 272 HIV-negative persons and 428 HIV-infected, treatment-naive patients were evaluated. Blood was collected from the participants when they came for specialised consultation in the University Teaching Hospital of Yaoundé. Biometric (body mass index, waist and hip circumference) and clinical (opportunistic infections) parameters were determined for each subject enrolled for the study. The 428 patients were put on four (4) different antiretroviral (ARV) drugs as follows: 201 patients on triple association nevirapine (NVP)/stavudine (d4T)/lamivudine (3TC), 177 on tritherapy efavirenz (EFV)/stavudine/lamivudine, 34 on combination lamivudine/zidovudine (AZT)/efavirenz, and 16 on association zidovudine/lamivudine/nevirapine. The bodily changes of patients were measured during a period of two years of follow up. The overall prevalence of lipodystrophy increased significantly with the lamivudine/stavudine/efavirenz ARV regimen, with breast lipodystrophy being the most frequent (15.92%; P = 0.038). In general, the lipodystrophy was more prevalent in: (1) HIV-infected, treatment-naïve patients with a CD 4 count less than 200 cells/mm 3 , and a viral load (VL) more than 10000 copies/mL, and (2) female patients above 31 years old on ARV with CD4 count more than 350 cells/μL and viral load less than 50 copies/mL. The waist and hip circumference of patients on ARV therapy were significantly higher than those of HIV-infected, treatment- naive patients, irrespective of treatment regimen. There seems to be a high risk of developing lipodystrophy by HIV-infected patients during ARV therapy. Further, in the treatment regimen that contains d4T and EFV, the risk of developing metabolic disorders seems to be high.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Nguemaim N. F”
  • BylineArticles whose byline prints “Mbuagbaw J”
  • BylineArticles whose byline prints “Teto G”
  • BylineArticles whose byline prints “Nkoa T”
  • BylineArticles whose byline prints “Same-Ekobo A”
  • BylineArticles whose byline prints “Asonganyi T”